Filtered By:
Condition: Heart Attack
Countries: Spain Health

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 127 results found since Jan 2013.

February 2019
From A to Zika : Understanding Emerging Diseases Control Your Cholesterol : Protect Yourself from Heart Attack and Stroke Vaping Rises Among Teens Wellness Tips in Spanish Weight Management
Source: NIH News in Health - January 31, 2019 Category: Consumer Health News Source Type: news

Impact of cardiovascular risk factors in the Extremadura population: HERMEX cohort contributions for a preventive strategy.
CONCLUSIONS: Hypertension confers the greatest burden of cardiovascular disease in the population of Extremadura, followed by hypercholesterolemia and smoking. These RF are priority objectives for a population-based preventive strategy. PMID: 30638699 [PubMed - as supplied by publisher]
Source: Atencion Primaria - January 9, 2019 Category: Primary Care Authors: Félix-Redondo FJ, Lozano Mera L, Alvarez-Palacios Arrighi P, Grau Magana M, Ramírez-Romero JM, Fernández-Bergés D Tags: Aten Primaria Source Type: research

Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
CONCLUSIONS: Nephrotoxicity with VAN was significantly higher than with DAP despite poorer basal renal status in the DAP group. PMID: 30630306 [PubMed - as supplied by publisher]
Source: Revista Espanola de Quimioterapia - January 8, 2019 Category: Drugs & Pharmacology Authors: Barberan J, Mensa J, Artero A, Epelde F, Rodriguez JC, Ruiz-Morales J, Calleja JL, Guerra JM, Martínez-Gil I, Giménez MJ, Granizo JJ, Aguilar L Tags: Rev Esp Quimioter Source Type: research

Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study
This study details the design of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study – a postauthorization observational study, which is part of the postapproval plan for edoxaban agreed with the European Medicines Agency. Methods The ETNA-AF-Europe study (Clinicaltrials.gov: NCT02944019) is a multicenter, prospective, observational study that enrolled 13 980 patients with atrial fibrillation treated with edoxaban from 852 sites across 10 European countries (Austria, Belgium, Germany, Ireland, Italy, the Netherlands, Portugal, Spain, Switzerland,...
Source: Journal of Cardiovascular Medicine - January 3, 2019 Category: Cardiology Tags: Research articles: Trial design Source Type: research

Total polyphenol intake, polyphenol subtypes and incidence of cardiovascular disease: The SUN cohort study
ConclusionThe intake of flavonoids showed an inverse association with risk of cardiovascular events in a prospective cohort of Spanish middle-aged adult university graduates.Registration number for clinical trialsNCT02669602 in Clinical Trials.
Source: Nutrition, Metabolism and Cardiovascular Diseases - October 5, 2018 Category: Nutrition Source Type: research

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Publication date: Available online 25 August 2018Source: The LancetAuthor(s): Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, Pascal Vranckx, Martina Rothenbühler, Matteo Tebaldi, Ferdinando Varbella, Paolo Calabrò, Stefano Garducci, Paolo Rubartelli, Carlo Briguori, Giuseppe Andó, Maurizio Ferrario, Ugo Limbruno, Roberto Garbo, Paolo Sganzerla, Filippo Russo, Marco Nazzaro, Alessandro Lupi, Bernardo CorteseSummaryBackgroundThe Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the comparative safety and effectiveness of ra...
Source: The Lancet - August 25, 2018 Category: General Medicine Source Type: research

Distribution of lipoprotein (a) in a population with cardiovascular events or dyslipidaemia
Aim: High level of lipoprotein(a) has been demonstrated to be an independent cardiovascular risk factor. However epidemiological data about Lp(a) levels in different patient cohorts are scarce. We aim to describe values of Lp(a) in a population of northern Spain with high cardiovascular risk (stroke or acute myocardial infarction) or dyslipidaemia.
Source: Atherosclerosis - August 1, 2018 Category: Cardiology Authors: A.R. Guerra Ruiz, B.A. Lavin Gomez, E.J. Palacio Portilla, Y. Jimenez Lopez, J.L. Hernandez Hernandez, C. Garc ía Ibarbia, N. Royuela Martinez, M.T. Garcia Unzueta, J.A. Vazquez de Prada Source Type: research

Involvement of mitochondrial haplogroups in myocardial infarction and stroke: A case-control study in Castile and Leon (Spain) population
Publication date: Available online 16 December 2017Source: MitochondrionAuthor(s): Miriam Umbria, Amanda Ramos, Jennifer Caner, Tomás Vega, José Eugenio Lozano, Cristina Santos, Maria Pilar AlujaAbstractThere are strong evidences that common mitochondrial DNA (mtDNA) haplogroups may influence the pathogenesis of cardiovascular diseases (CVDs). In this matched case-control study, we investigate the association between mtDNA haplogroups and two CVDs, myocardial infarction (MI) and stroke, and classical cardiovascular risk factors.Data obtained show that haplogroup H constitute a susceptibility risk factor for MI (p =&...
Source: Mitochondrion - July 11, 2018 Category: Biochemistry Source Type: research

Cost-effectiveness and Budget Impact of Treatment with Evolocumab Versus Statins and Ezetimibe for Hypercholesterolemia in Spain
ConclusionsTreatment with evolocumab is associated with a lower frequency of cardiovascular events, but is inefficient for patients suitable to receive this drug in the Spanish National Health System.ResumenIntroducción y objetivosAnalizar la razón de coste-efectividad y el impacto presupuestario del tratamiento con evolocumab (inhibidor de la PCSK9) para pacientes en prevención secundaria en el Sistema Nacional de Salud español.MétodosSe realizaron, desde la perspectiva del sistema sanitario público, análisis de impacto presupuestario, modelos de árbol de decisión y Markov, basándose en el único ensayo clínico...
Source: Revista Espanola de Cardiologia - July 10, 2018 Category: Cardiology Source Type: research

Involvement of mitochondrial haplogroups in myocardial infarction and stroke: A case-control study in Castile and Leon (Spain) population
Publication date: Available online 16 December 2017Source: MitochondrionAuthor(s): Miriam Umbria, Amanda Ramos, Jennifer Caner, Tomás Vega, José Eugenio Lozano, Cristina Santos, Maria Pilar AlujaAbstractThere are strong evidences that common mitochondrial DNA (mtDNA) haplogroups may influence the pathogenesis of cardiovascular diseases (CVDs). In this matched case-control study, we investigate the association between mtDNA haplogroups and two CVDs, myocardial infarction (MI) and stroke, and classical cardiovascular risk factors.Data obtained show that haplogroup H constitute a susceptibility risk factor for MI (p =&...
Source: Mitochondrion - July 5, 2018 Category: Biochemistry Source Type: research

Cost-effectiveness and Budget Impact of Treatment with Evolocumab Versus Statins and Ezetimibe for Hypercholesterolemia in Spain
ConclusionsTreatment with evolocumab is associated with a lower frequency of cardiovascular events, but is inefficient for patients suitable to receive this drug in the Spanish National Health System.ResumenIntroducción y objetivosAnalizar la razón de coste-efectividad y el impacto presupuestario del tratamiento con evolocumab (inhibidor de la PCSK9) para pacientes en prevención secundaria en el Sistema Nacional de Salud español.MétodosSe realizaron, desde la perspectiva del sistema sanitario público, análisis de impacto presupuestario, modelos de árbol de decisión y Markov, basándose en el único ensayo clínico...
Source: Revista Espanola de Cardiologia - July 5, 2018 Category: Cardiology Source Type: research

Mediterranean Diet Scores Again for Heart Health
WEDNESDAY, June 13, 2018 -- Eating a Mediterranean diet rich in healthy fats from olive oil and nuts provides better protection against heart attack and stroke than a low-fat diet, a new Spanish trial has shown. " Extensive research has found a...
Source: Drugs.com - Daily MedNews - June 13, 2018 Category: General Medicine Source Type: news

The Role of Frailty in Acute Coronary Syndromes in the Elderly
Conclusion: Frailty is an independent prognostic marker of the composite of mortality and reinfarction and of overall mortality in patients aged ≥75 years admitted due to MI.Gerontology
Source: Gerontology - June 1, 2018 Category: Geriatrics Source Type: research

Involvement of mitochondrial haplogroups in myocardial infarction and stroke: A case-control study in Castile and Leon (Spain) population
Publication date: Available online 16 December 2017 Source:Mitochondrion Author(s): Miriam Umbria, Amanda Ramos, Jennifer Caner, Tomás Vega, José Eugenio Lozano, Cristina Santos, Maria Pilar Aluja There are strong evidences that common mitochondrial DNA (mtDNA) haplogroups may influence the pathogenesis of cardiovascular diseases (CVDs). In this matched case-control study, we investigate the association between mtDNA haplogroups and two CVDs, myocardial infarction (MI) and stroke, and classical cardiovascular risk factors. Data obtained show that haplogroup H constitute a susceptibility risk factor for MI (p=0.001; OR=2...
Source: Mitochondrion - December 17, 2017 Category: Biochemistry Source Type: research